Autophagy activation via BAG3 gene therapy improves phenotype in a mouse model of LGMD1A

Burcak Ozes1, Lingying Tong1, Kyle Moss1

  • 1Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.

Molecular Therapy. Advances
|May 15, 2026
PubMed

Insights

Overexpressing BCL2-associated athanogene 3 (BAG3) protein in mice with myotilinopathy reduced protein aggregates and improved muscle function. This suggests BAG3 may be a therapeutic target for protein aggregate myopathies.

Area of Science:

  • Muscle biology
  • Proteinopathies
  • Autophagy

Background:

  • Myofibrillar myopathies (MFMs) involve protein aggregates and muscle fiber disintegration.
  • Myotilinopathy (MFM3/LGMD1A) stems from myotilin mutations, with impaired protein degradation pathways.
  • The autophagy-lysosome pathway (ALP) handles aggregate clearance when the ubiquitin-proteasome system is overloaded.

Purpose of the Study:

  • To evaluate the therapeutic potential of overexpressing human BAG3 (hBAG3) in a mouse model of myotilinopathy (TgT57I mice).
  • To assess if BAG3 overexpression can reduce muscle aggregate burden and improve muscle function.

Main Methods:

  • Systemic delivery of adeno-associated virus carrying hBAG3 (AAVrh74.tMCK.hBAG3) into TgT57I mice.
  • Functional assessments included rotarod, treadmill running, grip strength, and maximum tetanic response.
  • Histological and molecular analyses examined myotilin aggregate levels and autophagy markers.

Main Results:

  • hBAG3-treated mice showed significant improvements in all functional measures compared to controls.
  • Myotilin aggregate burden was substantially reduced, and autophagy levels were normalized post-treatment.
  • Endogenous Bag1/Bag3 ratio was normalized in hBAG3-treated mice, indicating adaptive response.

Conclusions:

  • Overexpression of BAG3 effectively reduces myotilin aggregate burden in a mouse model of myotilinopathy.
  • BAG3-based gene therapy demonstrates therapeutic potential for treating protein aggregate myopathies.
  • Restoring protein homeostasis via BAG3 modulation offers a promising therapeutic strategy.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...